367 related articles for article (PubMed ID: 29862557)
21. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract][Full Text] [Related]
23. Fenofibrate and Diosmetin in a rat model of testicular toxicity: New insight on their protective mechanism through PPAR-α/NRF-2/HO-1 signaling pathway.
Alqahtani MJ; Negm WA; Saad HM; Salem EA; Hussein IA; Ibrahim HA
Biomed Pharmacother; 2023 Sep; 165():115095. PubMed ID: 37413905
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.
Shin IS; Lee MY; Ha HK; Seo CS; Shin HK
BMC Complement Altern Med; 2012 Apr; 12():48. PubMed ID: 22520510
[TBL] [Abstract][Full Text] [Related]
26. Potential of Moringa oleifera in the Treatment of Benign Prostate Hyperplasia: Role of Antioxidant Defence Systems.
Ishola IO; Yemitan KO; Afolayan OO; Anunobi CC; Durojaiye TE
Med Princ Pract; 2018; 27(1):15-22. PubMed ID: 29248935
[TBL] [Abstract][Full Text] [Related]
27. α-Spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model.
Lee MY; Shin IS; Kyoung H; Seo CS; Son JK; Shin HK
Mol Med Rep; 2014 Jun; 9(6):2362-6. PubMed ID: 24682042
[TBL] [Abstract][Full Text] [Related]
28. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
29. [Rauwolfia extract inhibits the proliferation of prostate cells in rats with benign prostatic hyperplasia].
Liu B; Fang T; Liang L; Hu WJ; Dong M; Chen L; Wu W; Yun SF
Zhonghua Nan Ke Xue; 2023 Mar; 29(3):195-201. PubMed ID: 38597699
[TBL] [Abstract][Full Text] [Related]
30. Potential of telmisartan in the treatment of benign prostatic hyperplasia.
Ishola IO; Anunobi CC; Tijani KH; Afolayan O; Udokwu VU
Fundam Clin Pharmacol; 2017 Dec; 31(6):643-651. PubMed ID: 28727906
[TBL] [Abstract][Full Text] [Related]
31. PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System.
Yaribeygi H; Mohammadi MT; Sahebkar A
Drug Res (Stuttg); 2018 Jun; 68(6):355-360. PubMed ID: 29433142
[TBL] [Abstract][Full Text] [Related]
32. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.
Ishola IO; Tijani HK; Dosumu OO; Anunobi CC; Oshodi TO
Fundam Clin Pharmacol; 2017 Dec; 31(6):652-662. PubMed ID: 28636803
[TBL] [Abstract][Full Text] [Related]
34. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ
Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617
[TBL] [Abstract][Full Text] [Related]
35. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S
Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993
[TBL] [Abstract][Full Text] [Related]
36. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.
Peng Y; Peng C; Wu Y; Sun C; Li X
BMC Complement Med Ther; 2021 Oct; 21(1):272. PubMed ID: 34715848
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
[TBL] [Abstract][Full Text] [Related]
38. The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2.
Hong GL; Park SR; Jung DY; Karunasagara S; Lee KP; Koh EJ; Cho K; Park SS; Jung JY
J Ethnopharmacol; 2020 Mar; 250():112446. PubMed ID: 31812646
[TBL] [Abstract][Full Text] [Related]
39. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.
Said MM; Hassan NS; Schlicht MJ; Bosland MC
J Toxicol Environ Health A; 2015; 78(7):453-65. PubMed ID: 25785559
[TBL] [Abstract][Full Text] [Related]
40. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
